Dopamine and Renal Function and Blood Pressure Regulation

被引:69
作者
Armando, Ines [1 ]
Villar, Van Anthony M. [1 ]
Jose, Pedro A. [1 ]
机构
[1] Childrens Natl Med Ctr, Ctr Mol Physiol Res, Washington, DC 20010 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-COUPLED-RECEPTOR; NA-K-ATPASE; ATRIAL-NATRIURETIC-PEPTIDE; PROXIMAL TUBULE CELLS; ACUTE VOLUME EXPANSION; ANGIOTENSIN-II TYPE-1; LOW-DOSE DOPAMINE; SINGLE-NUCLEOTIDE POLYMORPHISMS; GLOMERULAR-FILTRATION-RATE; AMINO-ACID TRANSPORTERS;
D O I
10.1002/cphy.c100032
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Dopamine is an important regulator of systemic blood pressure via multiple mechanisms. It affects fluid and electrolyte balance by its actions on renal hemodynamics and epithelial ion and water transport and by regulation of hormones and humoral agents. The kidney synthesizes dopamine from circulating or filtered L-DOPA independently from innervation. The major determinants of the renal tubular synthesis/release of dopamine are probably sodium intake and intracellular sodium. Dopamine exerts its actions via two families of cell surface receptors, D-1-like receptors comprising D1R and D5R, and D-2-like receptors comprising D2R, D3R, and D4R, and by interactions with other G protein-coupled receptors. D-1-like receptors are linked to vasodilation, while the effect of D-2-like receptors on the vasculature is variable and probably dependent upon the state of nerve activity. Dopamine secreted into the tubular lumen acts mainly via D-1-like receptors in an autocrine/paracrine manner to regulate ion transport in the proximal and distal nephron. These effects are mediated mainly by tubular mechanisms and augmented by hemodynamic mechanisms. The natriuretic effect of D-1-like receptors is caused by inhibition of ion transport in the apical and basolateral membranes. D-2-like receptors participate in the inhibition of ion transport during conditions of euvolemia and moderate volume expansion. Dopamine also controls ion transport and blood pressure by regulating the production of reactive oxygen species and the inflammatory response. Essential hypertension is associated with abnormalities in dopamine production, receptor number, and/or posttranslational modification. (C) 2011 American Physiological Society. Compr Physiol 1:1075-1117, 2011.
引用
收藏
页码:1075 / 1117
页数:43
相关论文
共 721 条
[1]
Abdulla M. H., 2008, Autonomic & Autacoid Pharmacology, V28, P95, DOI 10.1111/j.1474-8673.2008.00422.x
[2]
A targeted mutation of the D-3 dopamine receptor gene is associated with hyperactivity in mice [J].
Accili, D ;
Fishburn, CS ;
Drago, J ;
Steiner, H ;
Lachowicz, JE ;
Park, BH ;
Gauda, EB ;
Lee, EJ ;
Cool, MH ;
Sibley, DR ;
Gerfen, CR ;
Westphal, H ;
Fuchs, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1945-1949
[3]
ADAM WR, 1985, RENAL PHYSIOL BIOCH, V8, P150
[4]
A Genome-Wide Association Study of Hypertension and Blood Pressure in African Americans [J].
Adeyemo, Adebowale ;
Gerry, Norman ;
Chen, Guanjie ;
Herbert, Alan ;
Doumatey, Ayo ;
Huang, Hanxia ;
Zhou, Jie ;
Lashley, Kerrie ;
Chen, Yuanxiu ;
Christman, Michael ;
Rotimi, Charles .
PLOS GENETICS, 2009, 5 (07)
[5]
Regulation of dopamine D1-receptor activation in vivo by protein phosphatase 2B (calcineurin) [J].
Adlersberg, M ;
Hsiung, SC ;
Glickstein, SB ;
Liu, KP ;
Tamir, H ;
Schmauss, C .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (04) :865-873
[6]
EVIDENCE FOR CHOLECYSTOKININ-DOPAMINE RECEPTOR INTERACTIONS IN THE CENTRAL NERVOUS-SYSTEM OF THE ADULT AND OLD RAT - STUDIES ON THEIR FUNCTIONAL MEANING [J].
AGNATI, LF ;
FUXE, K ;
GIARDINO, L ;
CALZA, L ;
ZOLI, M ;
BATTISTINI, N ;
BENFENATI, F ;
VANDERHAEGHEN, JJ ;
GUIDOLIN, D ;
RUGGERI, M ;
GOLDSTEIN, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) :315-333
[7]
EFFECTS OF EXTRACELLULAR FLUID VOLUME CHANGES ON RENAL RESPONSE TO LOW-DOSE DOPAMINE INFUSION IN NORMAL WOMEN [J].
AGNOLI, GC ;
CACCIARI, M ;
GARUTTI, C ;
IKONOMU, E ;
LENZI, P ;
MARCHETTI, G .
CLINICAL PHYSIOLOGY, 1987, 7 (06) :465-479
[8]
EFFECTS OF ISOTONIC SALINE LOADING ON RENAL TUBULAR AND NEUROGENIC DOPAMINE RELEASE IN CONSCIOUS RABBITS [J].
AKAMA, H ;
NOSHIRO, T ;
SANO, N ;
WATANABE, T ;
TRIGG, L ;
KOTSONIS, P ;
MAJEWSKI, H ;
MCGRATH, BP ;
MIURA, Y ;
ABE, K .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (6-7) :469-471
[9]
FACTORS AFFECTING THE RELEASE AND EXCRETION OF DOPAMINE IN THE RAT [J].
AKPAFFIONG, MJ ;
REDFERN, PH ;
WOODWARD, B .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (12) :839-843
[10]
Role of the D-1A dopamine receptor in the pathogenesis of genetic hypertension [J].
Albrecht, FE ;
Drago, J ;
Felder, RA ;
Printz, MP ;
Eisner, GM ;
Robillard, JE ;
Sibley, DR ;
Westphal, HJ ;
Jose, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2283-2288